Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 2000 Mar;53(3):201–205. doi: 10.1136/jcp.53.3.201

Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses

H C van Doorn 1, C Burger 1, P van der Valk 1, H Bonfrer 1
PMCID: PMC1731160  PMID: 10823139

Abstract

Aim—To investigate the correlation between immunohistochemical and biochemical steroid receptor analyses by measurement of oestrogen, progesterone, and androgen receptor status in ovarian neoplasia.

Methods—Tissue samples were obtained from 27 ovarian neoplasms, including two borderline tumours. Immunohistochemical staining of the tissue slides was scored semiquantitatively, incorporating the intensity and percentage of positive staining (histoscore). Tumours with a histoscore of 10 or more were considered steroid receptor positive. The epithelial and stromal fractions of the tumours were analysed separately. To study the uniformity of receptor expression throughout a tumour, up to four samples were analysed.

Results—Immunohistochemical histoscores of the oestrogen receptor in the epithelial fractions were significantly correlated with the biochemical oestrogen receptor values (r = 0.408). Androgen receptor status in the epithelial fraction was correlated with that in the stromal fraction (r = 0.741), while androgen receptor histoscores in the epithelial fraction correlated with the biochemical assay values (r = 0.463). On biochemical analysis, 17 of the 27 ovarian tumours were oestrogen receptor positive and seven were progesterone receptor positive. On immunohistochemical analysis, eight tumours were oestrogen receptor positive and two were progesterone receptor positive. Biochemical analysis showed that 14 of the 26 tumours were slightly androgen receptor positive (10–50 fmol/mg protein), while all the others were negative. On immunohistochemical analysis, seven of the 26 tumours were androgen receptor positive. When two or more specimens from one tumour were analysed, marked differences in steroid status were found, especially in progesterone receptor and androgen receptor expression. Some parts of a tumour were steroid receptor positive, while other parts were negative owing to heterogeneity of expression.

Conclusions—Immunohistochemical and biochemical analysis of steroid receptors in ovarian tumours correlated weakly or not at all. Heterogeneity of expression within a tumour and the presence of progesterone and androgen receptors in the stromal fraction partly accounted for this observation. Biochemical and immunohistochemical androgen receptor status was much lower than in previous reports.

Key Words: steroid receptors • ovarian neoplasia • immunohistochemical analysis • biochemical analysis

Full Text

The Full Text of this article is available as a PDF (116.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aasmundstad T. A., Haugen O. A., Johannesen E., Høe A. L., Kvinnsland S. Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods. J Clin Pathol. 1992 Feb;45(2):125–129. doi: 10.1136/jcp.45.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aziz D. C. Quantitation of estrogen and progesterone receptors by immunocytochemical and image analyses. Am J Clin Pathol. 1992 Jul;98(1):105–111. doi: 10.1093/ajcp/98.1.105. [DOI] [PubMed] [Google Scholar]
  3. Bosman F. T., de Goeij A. F., Rousch M. Quality control in immunocytochemistry: experiences with the oestrogen receptor assay. J Clin Pathol. 1992 Feb;45(2):120–124. doi: 10.1136/jcp.45.2.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  5. Chadha S., Rao B. R., Slotman B. J., van Vroonhoven C. C., van der Kwast T. H. An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors. Hum Pathol. 1993 Jan;24(1):90–95. doi: 10.1016/0046-8177(93)90067-q. [DOI] [PubMed] [Google Scholar]
  6. Chambers J. T., Carcangiu M. L., Voynick I. M., Schwartz P. E. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part II: Correlation between biochemical and immunohistochemical methods and survival. Am J Clin Pathol. 1990 Sep;94(3):255–260. doi: 10.1093/ajcp/94.3.255. [DOI] [PubMed] [Google Scholar]
  7. Friedlander M. L., Quinn M. A., Fortune D., Foo M. S., Toppila M., Hudson C. N., Russell P. The relationship of steroid receptor expression to nuclear DNA distribution and clinicopathological characteristics in epithelial ovarian tumors. Gynecol Oncol. 1989 Feb;32(2):184–190. doi: 10.1016/s0090-8258(89)80031-9. [DOI] [PubMed] [Google Scholar]
  8. Geyer H., Teufel G., de Gregorio G., Pfleiderer A. Steroidhormon-Rezeptoren beim Ovarialkarzinom und ihre klinische Bedeutung. Onkologie. 1984 May;7 (Suppl 2):44–52. doi: 10.1159/000215515. [DOI] [PubMed] [Google Scholar]
  9. Grénman S. E., Klemi P., Toikkanen S., Irjala K., Laippala P., Vähä-Eskeli K., Mäenpä J., Salmi T. Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma. Ann Chir Gynaecol Suppl. 1994;208:10–14. [PubMed] [Google Scholar]
  10. Grénman S. E., Klemi P., Toikkanen S., Kaihola H. L., Laippala P., Mäenpä J., Mäkinen J., Grönroos M. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma. Ann Chir Gynaecol Suppl. 1994;208:15–19. [PubMed] [Google Scholar]
  11. Iversen O. E., Skaarland E., Utaaker E. Steroid receptor content in human ovarian tumors: survival of patients with ovarian carcinoma related to steroid receptor content. Gynecol Oncol. 1986 Jan;23(1):65–76. doi: 10.1016/0090-8258(86)90117-4. [DOI] [PubMed] [Google Scholar]
  12. Koenders A., Thorpe S. M. Standardization of steroid receptor assays in human breast cancer--IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assays. Eur J Cancer Clin Oncol. 1986 Aug;22(8):945–952. doi: 10.1016/0277-5379(86)90061-1. [DOI] [PubMed] [Google Scholar]
  13. Kommoss F., Pfisterer J., Thome M., Schäfer W., Sauerbrei W., Pfleiderer A. Steroid receptors in ovarian carcinoma: immunohistochemical determination may lead to new aspects. Gynecol Oncol. 1992 Dec;47(3):317–322. doi: 10.1016/0090-8258(92)90133-4. [DOI] [PubMed] [Google Scholar]
  14. Korsten C. B., Persijn J. P. Evaluation of and additional data on an improved simple charcoal method to determine oestrogen receptors. J Clin Chem Clin Biochem. 1977 May;15(5):297–301. doi: 10.1515/cclm.1977.15.1-12.297. [DOI] [PubMed] [Google Scholar]
  15. Kühnel R., de Graaff J., Rao B. R., Stolk J. G. Androgen receptor predominance in human ovarian carcinoma. J Steroid Biochem. 1987 Mar;26(3):393–397. doi: 10.1016/0022-4731(87)90106-3. [DOI] [PubMed] [Google Scholar]
  16. Lantta M. Estradiol and progesterone receptors in normal ovary and ovarian tumors. Acta Obstet Gynecol Scand. 1984;63(6):497–503. doi: 10.3109/00016348409156709. [DOI] [PubMed] [Google Scholar]
  17. Molino A., Micciolo R., Turazza M., Bonetti F., Piubello Q., Corgnati A., Sperotto L., Martignoni G., Bonetti A., Nortilli R. Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. Breast Cancer Res Treat. 1995 Jun;34(3):221–228. doi: 10.1007/BF00689713. [DOI] [PubMed] [Google Scholar]
  18. Nyholm H. C., Nielsen A. L., Lyndrup J., Dreisler A., Thorpe S. M. Estrogen and progesterone receptors in endometrial carcinoma: comparison of immunohistochemical and biochemical analysis. Int J Gynecol Pathol. 1993 Jul;12(3):246–252. doi: 10.1097/00004347-199307000-00008. [DOI] [PubMed] [Google Scholar]
  19. Scheres H. M., De Goeij A. F., Rousch M. J., Hondius G. G., Willebrand D. D., Gijzen A. H., Bosman F. T. Quantification of oestrogen receptors in breast cancer: radiochemical assay on cytosols and cryostat sections compared with semiquantitative immunocytochemical analysis. J Clin Pathol. 1988 Jun;41(6):623–632. doi: 10.1136/jcp.41.6.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stierer M., Rosen H., Weber R., Hanak H., Spona J., Tüchler H. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors. Ann Surg. 1993 Jul;218(1):13–21. doi: 10.1097/00000658-199307000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. van Diest P. J., Weger D. R., Lindholm J. Reproducibility of subjective immunoscoring of steroid receptors in breast cancer. Anal Quant Cytol Histol. 1996 Oct;18(5):351–354. [PubMed] [Google Scholar]
  22. van der Vange N., Greggi S., Burger C. W., Kenemans P., Vermorken J. B. Experience with hormonal therapy in advanced epithelial ovarian cancer. Acta Oncol. 1995;34(6):813–820. doi: 10.3109/02841869509127191. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES